Cargando…
Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial
BACKGROUND: Brain scans are essential to exclude haemorrhage in patients with suspected acute ischaemic stroke before treatment with alteplase. However, patients with early ischaemic signs could be at increased risk of haemorrhage after alteplase treatment, and little information is available about...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Lancet Pub. Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513190/ https://www.ncbi.nlm.nih.gov/pubmed/25819484 http://dx.doi.org/10.1016/S1474-4422(15)00012-5 |
Ejemplares similares
-
The third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke
por: Sandercock, Peter, et al.
Publicado: (2008) -
Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial
Publicado: (2013) -
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial
Publicado: (2012) -
Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited
por: Sandercock, Peter, et al.
Publicado: (2011) -
The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke
por: Logallo, Nicola, et al.
Publicado: (2014)